These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31908796)

  • 1. Spatial variations in gut permeability are linked to type 1 diabetes development in non-obese diabetic mice.
    Joesten WC; Short AH; Kennedy MA
    BMJ Open Diabetes Res Care; 2019; 7(1):e000793. PubMed ID: 31908796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ameliorating gut microenvironment through staphylococcal nuclease-mediated intestinal NETs degradation for prevention of type 1 diabetes in NOD mice.
    Liang Y; Wang X; He D; You Q; Zhang T; Dong W; Fei J; Xing Y; Wu J
    Life Sci; 2019 Mar; 221():301-310. PubMed ID: 30776371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
    Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
    Front Immunol; 2019; 10():1733. PubMed ID: 31417546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats.
    Watts T; Berti I; Sapone A; Gerarduzzi T; Not T; Zielke R; Fasano A
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2916-21. PubMed ID: 15710870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frontline Science: Abnormalities in the gut mucosa of non-obese diabetic mice precede the onset of type 1 diabetes.
    Miranda MCG; Oliveira RP; Torres L; Aguiar SLF; Pinheiro-Rosa N; Lemos L; Guimarães MA; Reis D; Silveira T; Ferreira Ê; Moreira TG; Cara DC; Maioli TU; Kelsall BL; Carlos D; Faria AMC
    J Leukoc Biol; 2019 Sep; 106(3):513-529. PubMed ID: 31313381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in nonobese diabetic mice.
    Simon MC; Reinbeck AL; Wessel C; Heindirk J; Jelenik T; Kaul K; Arreguin-Cano J; Strom A; Blaut M; Bäckhed F; Burkart V; Roden M
    J Biol Chem; 2020 Jan; 295(4):969-980. PubMed ID: 31822562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-γ level in NOD mice.
    Krych Ł; Nielsen DS; Hansen AK; Hansen CH
    Gut Microbes; 2015; 6(2):101-9. PubMed ID: 25648687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
    Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
    ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incretin hormone expression in the gut of diabetic mice and rats.
    Berghöfer P; Peterson RG; Schneider K; Fehmann HC; Göke B
    Metabolism; 1997 Mar; 46(3):261-7. PubMed ID: 9054467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity.
    Wood Heickman LK; DeBoer MD; Fasano A
    Diabetes Metab Res Rev; 2020 Jul; 36(5):e3309. PubMed ID: 32162764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.
    Tanca A; Palomba A; Fraumene C; Manghina V; Silverman M; Uzzau S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice.
    Shen Y; You Q; Wu Y; Wu J
    Eur J Pharmacol; 2022 Feb; 916():174623. PubMed ID: 34767782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model.
    Sturgeon C; Lan J; Fasano A
    Ann N Y Acad Sci; 2017 Jun; 1397(1):130-142. PubMed ID: 28423466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives.
    Sapone A; de Magistris L; Pietzak M; Clemente MG; Tripathi A; Cucca F; Lampis R; Kryszak D; Cartenì M; Generoso M; Iafusco D; Prisco F; Laghi F; Riegler G; Carratu R; Counts D; Fasano A
    Diabetes; 2006 May; 55(5):1443-9. PubMed ID: 16644703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasma zonulin in patients with sepsis.
    Klaus DA; Motal MC; Burger-Klepp U; Marschalek C; Schmidt EM; Lebherz-Eichinger D; Krenn CG; Roth GA
    Biochem Med (Zagreb); 2013; 23(1):107-11. PubMed ID: 23457771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amelioration of Autoimmune Diabetes of NOD Mice by Immunomodulating Probiotics.
    Kim TK; Lee JC; Im SH; Lee MS
    Front Immunol; 2020; 11():1832. PubMed ID: 33013834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse.
    Hadjiyanni I; Li KK; Drucker DJ
    Endocrinology; 2009 Feb; 150(2):592-9. PubMed ID: 18845625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of diabetic state on co-localization of substance P and serotonin in the gut in animal models.
    Spångéus A; Forsgren S; El-Salhy M
    Histol Histopathol; 2001 Apr; 16(2):393-8. PubMed ID: 11332694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for assessment of intestinal permeability in clinical practice.
    Seethaler B; Basrai M; Neyrinck AM; Nazare JA; Walter J; Delzenne NM; Bischoff SC
    Am J Physiol Gastrointest Liver Physiol; 2021 Jul; 321(1):G11-G17. PubMed ID: 34009040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota from B-cell-specific TLR9-deficient NOD mice promote IL-10
    Yang X; Huang J; Peng J; Wang P; Wong FS; Wang R; Wang D; Wen L
    Front Immunol; 2024; 15():1413177. PubMed ID: 38903498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.